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Introduction
Cardiac 31P-MRS is the only non-invasive in vivo tech-
nique for the determination of cardiac high energy phos-
phate metabolism. Changes in cardiac phosphocreatine
to adenosine triphosphate ratios (PCr/ATP) occur in com-
mon cardiac pathologies and have diagnostic, prognostic
and therapeutic utility. However, long acquisition times
(20 minutes or more, depending on heart rate) required
to achieve sufficient signal to noise ratios for reliable
interpretation have limited the clinical utility of 31P-MRS
studies in patients with severe cardiac disease.
We have developed an 8 minute 31P-MRS protocol and
demonstrate the validity of this 'short' acquisition by
comparison with a 'long' (at least 20 minutes) method of
published reproducibility (Tyler, NMR Biomed:2008).
Purpose
To design a robust, 'short' cardiac 31P-magnetic reso-
nance spectroscopy (31P- MRS) protocol which facilitates
acquisition within a clinically acceptable timeframe.
Methods
Protocol development
This 'short' protocol essentially incorporates a larger voxel
(93 mls compared to 39 mls for 'long' protocol) but elim-
inates extra myocardial contamination by:
• active suppression of chest wall muscle and liver signals,
• raw data acquisition weighted to reduce contamination
arising from outside the nominal voxel.
The accuracy of the data and its interpretation is improved
by:
• optimised radio frequency (RF) pulse,
• flip angle calibration (at voxel of interest) used during
post-processing to calculate and correct for subject varia-
tion to coil loading.
• calibrated signal enhancement (Nuclear Overhauser
Enhancement (NOE)),
• rapid repetition time (with calibrated saturation correc-
tion).
Validity
22 healthy volunteers (age 42 ± 16.5; 13 males, 9
females), were scanned (3 T Siemens Trio) with both the
'long' and 'short' acquisitions.
Acquisition parameters for both protocols are summa-
rised and compared in Table 1.
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There was no difference of derived PCr/ATP ratios for both
methods ('short' 1.83 ± 0.32; 'long' 1.78 ± 0.27). Bland-
Altman analysis demonstrates excellent agreement
between the two methods (Figure 1) confirming equiva-
lence for clinical purposes. Figure 2 shows an example of
spectra acquired from one subject, using both methods.
Conclusion
We have developed a novel 'short' cardiac 31P-MRS pro-
tocol of high data quality. This protocol allows cardiac
spectroscopy to be measured in patients who are often
intolerant of long acquisition times, such as those with
severe cardiac disease and children. Hence this work pro-
vides a useful tool for the routine clinical assessment of
cardiac 31P-MRS.
Table 1: Selected acquisition properties of compred protocols
Control (long, 20 min) protocol Short (8 min) protocol
3D CSI Matric size 16 × 16 × 16 16 × 8 × 8
Field of view 240 × 240 × 240 mm 240 × 240 × 240 mm
Voxel size 29 mls 93 mls
Cardiac gated Yes No, TR 720 ms
Acquisition time >+ = 20 mins 8 min
Chest wall muscle saturation Yes Yes
Liver saturation No Yes
NOE Yes Yes
RF saturation, NOE and blood correction factors applied Yes Yes
Subject specific flip angle map acquired Yes Yes
PCr/ATP ration derived from data acquired with the 'long' versus the 'short' 31P-MRS ethods using a Bland Altman plotFigure 1
PCr/ATP ration derived from data acquired with the 
'long' versus the 'short' 31P-MRS methods using a 
Bland Altman plot.
Comparing spectroscopy for one subject (heart rate 60), requiring 28 minutes for the 'long' control acquisition vs the new 'short' (8 minute) protocalFigure 2
Comparing spectroscopy for one subject (heart rate 60), requiring 28 minutes for the 'long' control acquisition 
vs the new 'short' (8 minute) protocal. PCr (phosphocreatine); 2, 3 DPG (2, 3 diphosphoglycerate); ATP (adenosinetri-
phosphate) are indicated.Page 2 of 2
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